TY - JOUR
T1 - In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation
AU - Siemasko, Karyn F.
AU - Gao, Jianping
AU - Calder, Virginia L.
AU - Hanna, Rebecca
AU - Calonge, Margarita
AU - Pflugfelder, Stephen C.
AU - Niederkorn, Jerry Y.
AU - Stern, Michael E.
PY - 2008
Y1 - 2008
N2 - PURPOSE. To determine whether in vitro expanded CD4+CD25 +Foxp3+ regulatory T cells can suppress immune-mediated ocular surface inflammation in a mouse model of dry eye. METHODS. C57BL/6 or BALB/c mice were exposed to a dry, desiccating environment produced by maintaining low humidity (<40%), injections of scopolamine, and air flow produced by a fan. CD4+CD25+ regulatory T cells were isolated and expanded in vitro in the presence of rmIL-2 and beads coated with anti-CD28 and anti-CD3. In vitro expanded regulatory T cells were phenotypically compared with freshly isolated regulatory T cells by flow cytometry and immunofluorescence. T-cell-deficient nude mice were reconstituted with CD4 + T-effector cells from donor mice exposed to a desiccating environment for 5 days, in combination with or without freshly isolated or in vitro expanded regulatory T cells. Tear cytokine levels were determined by a multiplex bead-based immunoassay. RESULTS. In vitro regulatory T cells maintained normal levels of CD4+, CD25+, and intracellular Foxp3+, as determined by flow cytometry and immunohistochemistry. Freshly isolated and in vitro regulatory T cells were titrated in the presence of CD4+ pathogenic T cells (CD4+Path T cells) in reconstitution experiments and most efficiently ablated tear cytokine levels and conjunctival cellular infiltration at a ratio of 1:1 (T Regs: CD4 +Path). CONCLUSIONS. Regulatory T cells expressed CD4+, CD25+, and intracellular Foxp3+ at normal levels and retained their inhibitory function after in vitro expansion, providing a useful tool to determine the mechanism regulatory T cells use to sustain a homeostatic environment on the ocular surface.
AB - PURPOSE. To determine whether in vitro expanded CD4+CD25 +Foxp3+ regulatory T cells can suppress immune-mediated ocular surface inflammation in a mouse model of dry eye. METHODS. C57BL/6 or BALB/c mice were exposed to a dry, desiccating environment produced by maintaining low humidity (<40%), injections of scopolamine, and air flow produced by a fan. CD4+CD25+ regulatory T cells were isolated and expanded in vitro in the presence of rmIL-2 and beads coated with anti-CD28 and anti-CD3. In vitro expanded regulatory T cells were phenotypically compared with freshly isolated regulatory T cells by flow cytometry and immunofluorescence. T-cell-deficient nude mice were reconstituted with CD4 + T-effector cells from donor mice exposed to a desiccating environment for 5 days, in combination with or without freshly isolated or in vitro expanded regulatory T cells. Tear cytokine levels were determined by a multiplex bead-based immunoassay. RESULTS. In vitro regulatory T cells maintained normal levels of CD4+, CD25+, and intracellular Foxp3+, as determined by flow cytometry and immunohistochemistry. Freshly isolated and in vitro regulatory T cells were titrated in the presence of CD4+ pathogenic T cells (CD4+Path T cells) in reconstitution experiments and most efficiently ablated tear cytokine levels and conjunctival cellular infiltration at a ratio of 1:1 (T Regs: CD4 +Path). CONCLUSIONS. Regulatory T cells expressed CD4+, CD25+, and intracellular Foxp3+ at normal levels and retained their inhibitory function after in vitro expansion, providing a useful tool to determine the mechanism regulatory T cells use to sustain a homeostatic environment on the ocular surface.
UR - http://www.scopus.com/inward/record.url?scp=58149241191&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149241191&partnerID=8YFLogxK
U2 - 10.1167/iovs.08-2075
DO - 10.1167/iovs.08-2075
M3 - Article
C2 - 18658093
AN - SCOPUS:58149241191
SN - 0146-0404
VL - 49
SP - 5434
EP - 5440
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
IS - 12
ER -